The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes
Open accessAbstract
Aim: To report presentation and outcome of rhino-orbital-cerebral mucormycosis (ROCM) exclusively in patients with diabetes mellitus. Methods: Retrospective, non-comparative, interventional analysis of the medical records of 35 patients with ROCM among 22 316 patients with diabetes seen over the last 12 years. Results: A cohort of 23 men and 12 women with a mean (SD) age of 47.3 (14.4) years (range 18–70 years) was studied. Five patients had type 1 diabetes mellitus, 29 had type 2 diabetes mellitus, and one had secondary diabetes. Nine patients had ROCM as the first clinical manifestation of diabetes. The mean (SD) blood glucose at presentation was 20.6 (8.3) mmol/l (range 10.0 to 53.3 mmol/l) and 17 patients had ketosis/ketoacidosis. Ophthalmic symptoms and signs were pronounced: external ophthalmoplegia (89%), proptosis (83%), visual loss (80%), chemosis (74%), and eye lid gangrene (14%). Non-ophthalmic manifestations included sinusitis (100%), nasal discharge/ulceration (74%), infranuclear VI nerve palsy (46%), palatal necrosis (29%), cerebral lobe involvement (20%), and hemiparesis (17%). Computed tomography/magnetic resonance imaging showed involvement of paranasal sinuses in all patients with ethmoid (86%) and maxillary (80%) sinuses being most frequently involved. Orbital involvement was observed in 80% of patients with cavernous sinus thrombosis in 11%, and internal carotid occlusion and hydrocephalus in 3% each. All were treated with amphotericin B (3–3.5 g) and 26 (74%) patients underwent appropriate surgery. Twenty one patients (68%) survived with a mean (SD) follow up of 39.6 (34.1) months (range 10 months to 11 years). Factors related to poor survival included delay in diagnosis and treatment (p<0.05), facial and/or eye lid gangrene (p<0.05), hemiplegia (p<0.05), cerebral invasion by mucorales (p<0.05), and treatment with amphotericin B alone (p<0.05). Conclusions: In patients with diabetes and ROCM, ROCM was the presenting manifestation in one fourth of the patients. Ophthalmic and extensive cerebral involvement predominated in the clinical picture. Delay in treatment due to late presentation and associated complications were major determinants of the survival outcome in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survival factors in rhino-orbital-cerebral mucormycosis
Yohai, R. A., Bullock, J. D., Aziz, A. A., & Markert, R. J. (1994) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80041-4 · Cited by 492
Artis, W. M., Fountain, J. A., Delcher, H. K., & Jones, H. E. (1982) · Diabetes · doi:10.2337/diabetes.31.12.1109 · Cited by 369
Improved Diagnosis and Prognosis of Mucormyucosis: A CLINICOPATHOLOGIC STUDY OF 33 CASES
PARFREY, N. A. (1986) · Medicine · doi:10.1097/00005792-198603000-00004 · Cited by 321
Patient survival factors in paranasal sinus mucormycosis
Blitzer, A., Lawson, W., Meyers, B. R., & Biller, H. F. (1980) · The Laryngoscope · doi:10.1288/00005537-198004000-00010 · Cited by 286
ABRAMSON, E., WILSON, D., & ARKY, R. A. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-4-735 · Cited by 171
Pillsbury, H. C., & Fischer, N. D. (1977) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1977.00780270068011 · Cited by 170
The changing spectrum of disease, etiology, and diagnosis of mucormycosis
Marchevsky, A. M., Bottone, E. J., Geller, S. A., et al. (1980) · Human Pathology · doi:10.1016/s0046-8177(80)80054-2 · Cited by 154
An Improved Method for the Isolation of Islets from the Beef Pancreas
Lacy, P. E., Lacy, E. T., FINKE, E. H., & Yasunami, Y. (1982) · Diabetes · doi:10.2337/diab.31.4.s109 · Cited by 59
Cited by
Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Epidemiology and Clinical Manifestations of Mucormycosis
Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T. J., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir866 · Cited by 1,452
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Cornely, O. A., Arikan-Akdagli, S., Dannaoui, E., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 863
Epidemiology of Mucormycosis in India
Prakash, H., & Chakrabarti, A. (2021) · Microorganisms · doi:10.3390/microorganisms9030523 · Cited by 441
A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment
Prakash, H., Ghosh, A. K., Rudramurthy, S. M., Singh, P., Xess, I., Savio, J., Pamidimukkala, U., Jillwin, J., Varma, S., Das, A., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myy060 · Cited by 389
Self-citationZygomycosis: the re-emerging fungal infection
Chayakulkeeree, M., Ghannoum, M. A., & Perfect, J. R. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0107-1 · Cited by 368
Turner, J. H., Soudry, E., Nayak, J. V., & Hwang, P. H. (2013) · The Laryngoscope · doi:10.1002/lary.23912 · Cited by 353
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Pal, R., Singh, B., Bhadada, S. K., Banerjee, M., Bhogal, R. S., Hage, N., & Kumar, A. (2021) · Mycoses · doi:10.1111/myc.13338 · Cited by 289
Self-citationInvasive Zygomycosis: Update on Pathogenesis, Clinical Manifestations, and Management
Kontoyiannis, D. P., & Lewis, R. E. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.003 · Cited by 261
Metadata
- Authors
- Bhansali, A., Bhadada, S., Sharma, A., Suresh, V, Gupta, A., Singh, P., Chakarbarti, A., & Dash, R. J.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11
- Volume
- 80
- Issue
- 949
- Pages
- 670-674
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2128107052
- Cited by
- 263
- References
- 8
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.